CTRI/2024/02/063069尚未招募4 期
A comparative study of fesoterodine vs mirabegron vs solifenacin in cases of overactive bladder. - NI
VYOMA DESAI0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All cases of overactive bladder undergoing treatment at Dr. PSIMS and RF hospital
排除标准
- •Patients not willing to participate in the study
- •Patients lost to follow up
- •Patients less than 18 years of age
研究者
相似试验
未知
4 期
Comparison of fesoterodine and mirabegron in the treatment of female overactive baldder patients with urgency incontinence: A randomized, prospective study (Feminine study)overactive bladderJPRN-UMIN000024442Department of urology, Nagoya University Graduate School of Medicine300
尚未招募
不适用
Prospective comparison of mirabegron and fesoterodine for overactive bladderOveractive bladder(OAB)JPRN-UMIN000045947agasaki University Hospital Department of urology140
尚未招募
不适用
Add on Effect of Fesoterodine and Vibegron for Male Overactive Bladder Treated with Tadalafil Multicenter Randomized Comparative Studyoveractive bladderJPRN-UMIN000038483Department of Renal and Urologic Surgery, Asahikawa Medical University280
已完成
不适用
Comparison of Mirabegron and Imidafenacin for efficacy and safety in Japanese female patients with overactive bladder: A randomized controlled trial (COMFORT Study).Overactive bladderJPRN-UMIN000010321Department of Urology, Hamamatsu University School of Medicine200
已完成
不适用
rodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladderneurogenic bladderJPRN-UMIN000037584Dokkyo Medical University77